Unilever Reviews Food Business in Ongoing Portfolio Reshape, Reinforcing Transformation Amid High Valuation

What happened

Unilever has advanced its portfolio reshaping by placing its legacy food business under review, aligning with its broader Growth Action Plan to focus on higher-growth segments like Beauty & Wellbeing. The company reported solid 2025 results, including 3.5% underlying sales growth and €5.9 billion in free cash flow, demonstrating resilient performance despite macroeconomic headwinds. This move follows the planned Ice Cream demerger and an €800 million productivity program, part of a complex transformation aimed at improving growth and margins. However, Unilever's stock trades at a rich ~32x P/E, approximately 39% above intrinsic value per FMP's DCF, offering a thin margin of safety. Investors have seen minimal share price progress over five years, reflecting skepticism about the execution risks and potential dis-synergies from these strategic shifts.

Implication

The food business review could unlock value by shedding slower-growth assets, but it introduces new risks, such as reduced bargaining power and operational disruption, which must be weighed against benefits. Execution of the broader transformation, including the Ice Cream demerger and cost savings, remains critical to delivering sustainable growth and margin expansion. Unilever's high valuation at ~32x P/E, combined with its history of stagnant share performance, suggests limited upside unless the transformation yields clear, accelerated results. Robust free cash flow and a conservative balance sheet provide defensive support, but growth is only in the low- to mid-single digits, constraining near-term catalysts. Overall, existing holders may consider trimming positions, and new capital is better deployed after a price correction or proven execution success.

Thesis delta

The news reinforces the existing thesis that Unilever's transformation is ongoing and carries significant execution risk, with the food business review adding another layer of complexity. It does not materially alter the view that the stock is overvalued relative to intrinsic value, maintaining the potential sell bias. However, it highlights management's continued efforts to reshape the portfolio, which could improve long-term prospects if successfully implemented, but requires vigilant monitoring.